Summit Scale and Participation

  • The summit attracted 120+ senior pharma attendees, with 50% being decision makers and sponsors
  • 70% of attendees were Director-level or above
  • Representation spanned commercial, medical, digital, technology, and enterprise leadership functions
  • Strong participation from both large pharma and emerging biopharma companies
  • Featured 8 panels and presentations totaling 410+ minutes of sessions

Keynote Speakers and Participants

  • David Shulkin, Ninth Secretary of U.S. Department of Veterans Affairs
  • Amol Punjabi, Chief Product Officer of OpenEvidence
  • Agam Upadhyay, Chief Digital & Information Officer of Vertex
  • Corinne Le Goff, Chief Commercial Officer of Viatris
  • Expanded speaker roster with greater executive representation than previous editions

Strategic Themes and Focus Areas

  • Shifted industry conversation from "How can AI work in Pharma?" to "How do we operationalize AI at scale?"
  • Focus on AI operating models, customer engagement, enterprise transformation, and future of work
  • Emphasis on moving from AI experimentation to enterprise transformation
  • Discussion of AI-mediated discovery and evidence-led engagement

Indegene's Capabilities Demonstration

  • Indegene's AI and platform capabilities emerged as one of the strongest themes of the summit
  • 8 sessions explored AI impact and performance from industry, leader, and capability perspectives
  • Featured an "Indegene AI Experience Zone" showing integrated end-to-end experience across strategy, content, and engagement
  • Transitioned from isolated capability kiosks in previous years to connected client journey

Industry Impact and Positioning

  • IDS is becoming a flagship platform for "Future Ready Healthcare"
  • Established differentiation as a platform for peer-to-peer exchange
  • Celebrated industry leadership through "Vital Awards" recognizing leaders driving measurable impact across healthcare
  • Strengthened executive engagement across the U.S. life sciences ecosystem
  • Delivered premium executive experience with 'Freedom Rising Show' and other experience zones

Key Takeaways from Sessions

1. AI success depends on reimagined operating models, not technology alone

2. Customer attention shifting toward AI-mediated discovery and evidence-led engagement

3. Governance, workflow redesign, and business ownership critical for enterprise scale

4. Agile organizations will outperform by combining human expertise, AI intelligence, and continuous learning

5. Next competitive advantage will come from turning AI capability into measurable business performance

What IDS 2026 Signals

  • For the Industry: Shift from AI experimentation to enterprise transformation
  • For Clients: Trusted platform to exchange ideas and accelerate change
  • For Indegene: Growing influence as strategic partner, AI innovator, and industry convenor
  • For Investors: Evidence that Indegene's investments in AI, platforms, domain expertise, and ecosystem leadership are strengthening its strategic position within life sciences

Venue and Location Strategy

  • Held at National Constitution Center, Philadelphia, reinforcing focus on leadership, transformation, and future of life sciences
  • Venue selection reinforced Indegene's strength in the U.S. market
  • Enabled deeper engagement with existing and prospective clients through premium experiences